Description
Retatrutide is a Multi-Receptor Compound for Metabolic and Weight Management Research.
Retatrutide is a novel research compound designed for the investigation of advanced metabolic pathways and weight regulation mechanisms. As a triple-agonist targeting GLP-1, GIP, and glucagon receptors, it is a promising compound in preclinical research models focusing on energy balance, fat metabolism, and glucose homeostasis.
Product Overview: Each vial contains 10mg of high-purity lyophilised Retatrutide, ideal for controlled studies examining its multi-pathway action. Researchers utilise this compound to explore its potential effects on insulin sensitivity, lipid oxidation, and appetite regulation, contributing to the growing field of metabolic disorder treatment models.
Click to access Protocols-3.pdf
Key Research Attributes:
- Triple-Receptor Agonism: Simultaneously activates GLP-1, GIP, and glucagon receptors, enabling research into synergistic effects on metabolism and weight modulation.
- Metabolic Disorder Applications: Frequently used in studies related to obesity, type 2 diabetes, and insulin resistance mechanisms.
- Energy Balance Modulation: Investigated for its ability to reduce food intake, enhance thermogenesis, and improve glycemic control in animal models.
- Laboratory-Grade Purity: Formulated for stability, accuracy, and consistency across experimental trials in metabolic and endocrinology labs.
Applications in Scientific Research
- GLP-1/GIP/glucagon receptor signalling studies
- Obesity and fat oxidation research models
- Preclinical evaluation of multi-targeted weight loss peptides
- Endocrine regulation and appetite hormone analysis
- Type 2 diabetes and insulin response studies
Format and Storage Form: Lyophilised powder Purity: >99% Storage: Store at -20°C for optimal long-term stability Reconstitution: Use bacteriostatic water for preparation in laboratory settings
Disclaimer: Retatrutide is supplied strictly for research and in vitro laboratory use. It is not intended for human or veterinary application. All usage must comply with institutional and regulatory guidelines.




Reviews
There are no reviews yet.